These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37749082)

  • 1. Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer.
    Cao Y; Tang H; Wang G; Li P; Song Z; Li W; Sun X; Zhong X; Yu Q; Zhu S; Zhu L
    Cell Death Discov; 2023 Sep; 9(1):351. PubMed ID: 37749082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA Alleviates the Biological Characteristics of Colorectal Cancer via Activating the ROS/JNK Signaling Pathway.
    Qian J; Cao Y; Zhang J; Li L; Wu J; Yu J; Huo J
    Anticancer Agents Med Chem; 2023; 23(2):227-236. PubMed ID: 35593352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway.
    Zhang Y; Ge T; Xiang P; Zhou J; Tang S; Mao H; Tang Q
    Onco Targets Ther; 2019; 12():9725-9734. PubMed ID: 32009805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin degradation by bergenin overcomes pemetrexed resistance.
    Li X; Liang Q; Zhou L; Deng G; Xiao Y; Gan Y; Han S; Liao J; Wang R; Qing X; Li W
    Cell Oncol (Dordr); 2023 Dec; 46(6):1837-1853. PubMed ID: 37542022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance.
    Dong X; Liu W; Li X; Gan Y; Zhou L; Li W; Xie L
    Sci Rep; 2022 Nov; 12(1):20644. PubMed ID: 36450751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer Cells.
    Gao F; Li M; Liu W; Li W
    Onco Targets Ther; 2020; 13():2757-2769. PubMed ID: 32308411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA regulates colorectal cancer apoptosis via attenuation of Parkin‑mediated mitophagy by suppressing AMPK/Skp2 pathways.
    He L; Gu K
    Mol Med Rep; 2018 Aug; 18(2):1692-1703. PubMed ID: 29845197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer.
    Song Q; Yang L; Han Z; Wu X; Li R; Zhou L; Liu N; Sui H; Cai J; Wang Y; Ji Q; Li Q
    Front Pharmacol; 2020; 11():586616. PubMed ID: 33192529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits cell viability and promotes PUMA-mediated apoptosis of oral squamous cell carcinoma.
    Han S; Yu X; Wang R; Wang X; Liu L; Zhao Q; Xie R; Li M; Zhou ZS
    J Cancer; 2023; 14(13):2481-2490. PubMed ID: 37670974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis.
    Ge T; Zhang Y
    Open Med (Wars); 2022; 17(1):1228-1240. PubMed ID: 35892081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrodin destabilizes survivin and overcomes pemetrexed resistance.
    Liao J; Qing X; Deng G; Xiao Y; Fu Y; Han S; Li X; Gan Y; Li W
    Cell Signal; 2023 Oct; 110():110851. PubMed ID: 37586466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Jiao JW; Wen F
    Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K/Akt pathway.
    Zhang Y; Geng Y; He J; Wu D; Zhang T; Xue L; Zhang L; He A
    Am J Transl Res; 2019; 11(5):2995-3006. PubMed ID: 31217869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
    Deng H; Yu B; Li Y
    Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
    Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
    J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
    Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH
    Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
    Lu M; Wang C; Wang J
    Int J Oncol; 2016 Aug; 49(2):603-10. PubMed ID: 27279458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
    Zhou L; Sui H; Wang T; Jia R; Zhang Z; Fu J; Feng Y; Liu N; Ji Q; Wang Y; Zhang B; Li Q; Li Y
    Oncol Rep; 2020 Apr; 43(4):1159-1168. PubMed ID: 32323837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.